Gil
Analyst
Needham
Equibles does not estimate personal net worth.
About Gil
Gil is recorded as Analyst at Needham. Gil has spoken on 2 investor events across 2 companies, most recently for TScan Therapeutics, Inc. on April 15, 2026. Those appearances were for TScan Therapeutics, Inc. (TCRX) and Nurix Therapeutics, Inc. (NRIX). The companies whose calls Gil spoke on are classified in the Healthcare sector.
Gil on recent calls
“Good afternoon, everyone, and thank you for joining us the third day of the Needham Healthcare Conference. It is my pleasure to have with me today Gavin McBeth, CEO of T-Scan.”
“It is my pleasure to have with me today Dr. Arthur Sands, who's president and CEO of Nurex. And as a reminder, viewers who are watching can submit questions for the ask the question box.”
Affiliation history
-
Needham
Analyst
Transcript header (unverified)
Current